Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease.
about
Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary ImmunodeficienciesNox2 is a mediator of ischemia reperfusion injury.Chronic Granulomatous Disease Mimicking Colonic Crohn's Disease Successfully Treated with Infliximab.Hyper-responsive Toll-like receptor 7 and 9 activation in NADPH oxidase-deficient B lymphoblasts.A Critical Reappraisal of Neutrophil Extracellular Traps and NETosis Mimics Based on Differential Requirements for Protein Citrullination.New insights into the immunopathogenesis of systemic lupus erythematosus.Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease.CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease.Role of Flow Cytometry in the Diagnosis of Chronic Granulomatous Disease: the Egyptian Experience.Nox2 and Cyclosporine-Induced Renal Hypoxia.Raised Serum IL-8 Levels Are Associated with Excessive Fatigue in Female Carriers of X-Linked Chronic Granulomatous Disease in the UK.NADPH Oxidase Deficiency: A Multisystem Approach.Mastoidectomy in a child with chronic granulomatous disease.CD40 ligand deficiency causes functional defects of peripheral neutrophils that are improved by exogenous IFN-γ.Chronic Granulomatous Disease.Considerations in the Diagnosis of Chronic Granulomatous Disease.Noninfectious Manifestations and Complications of Chronic Granulomatous Disease.Chronic Granulomatous Disease: Epidemiology, Pathophysiology, and Genetic Basis of Disease.Monogenic Lupus: A Developing Paradigm of Disease
P2860
Q28066193-D8A830D5-DC23-4DC2-968F-6ADC24571C5BQ36259413-FFF9142E-C940-499F-9F3F-4760699FAB96Q37727688-CB2943A6-0E17-46FF-9A11-BB2B9068C928Q38837849-E89FE764-5D12-42D6-B76B-ABA5A1A578FDQ39014892-38573D09-345C-46A2-895C-5F7C716B24B4Q39016144-A8EE26D0-D5CC-49BC-9D0C-043238BAF312Q39684886-DD408363-6309-432A-80AD-02B3649DB640Q40375767-77145A02-390D-4CE8-84E5-71763F82FC2AQ40660871-0A281C56-B6C6-4EC5-BB5D-93C57E0FB492Q42772736-89CAD504-222C-46A1-A3FF-225D809F59FFQ47817732-18CDE9C6-754A-437E-8815-A44BF4B3DFDEQ49422978-D297DE4D-B44C-495F-B2AB-1D6496165E09Q50093392-D6572C4A-19DC-408C-BC2B-1D77AEEB4457Q52666648-B5EEF828-5AF1-4B93-BB7D-A34C47FF2A7EQ53261887-1B38281E-8E6E-4CCC-AAE5-BF6C3232EA93Q54215574-CBBC86D2-AFAB-4B33-A4AC-77246196C7AFQ55021826-7DBA5CFE-9FF0-498D-94CF-26970FC922F8Q55385710-3931690F-524D-4846-9A8C-A96DDD97AD44Q59136338-B96CC01C-7094-45C7-81F2-1DFB7A50FA62
P2860
Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease.
@en
type
label
Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease.
@en
prefLabel
Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease.
@en
P2093
P2860
P1476
Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease.
@en
P2093
A C Battersby
A R Gennery
P2860
P2888
P304
P356
10.1007/S10875-013-9939-5
P577
2013-11-01T00:00:00Z
P6179
1006498586